Suchergebnisse - "Sundahl, Nora"

PubPharm (9)

1

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

enthalten in: BMC cancer | 2021

von Spaas, M. | Sundahl, N. | Hulstaert, E. | +14

2

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial

enthalten in: BMC cancer | 2021

von Spaas, M. | Sundahl, N. | Hulstaert, E. | +14

3

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score

enthalten in: Radiation oncology (London, England) | 2020

von Schaule, J. | Kroeze, S. | Blanck, O. | +18

ErratumIn: Radiat Oncol. 2020 Dec 14;15(1):280. - PMID 33317582

4

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy

enthalten in: Radiation oncology | 2020

von Schaule, J. | Kroeze, S. | Blanck, O. | +18

5

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy

enthalten in: Radiation oncology | 2020

von Schaule, J. | Kroeze, S. | Blanck, O. | +18

6

Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma

enthalten in: European urology | 2019

von Sundahl, N. | Vandekerkhove, G. | Decaestecker, K. | +14

7

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response

enthalten in: Journal of translational medicine | 2017

von Sundahl, N. | De Wolf, K. | Rottey, S. | +11

8

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response

enthalten in: Journal of translational medicine | 2017

von Sundahl, N. | De Wolf, K. | Rottey, S. | +11

9

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response

enthalten in: Journal of translational medicine | 2017

von Sundahl, N. | De Wolf, K. | Rottey, S. | +11

1
[1]